RE-BVS – Piemonte Repository

Sfoglia per AUTORE
COSTA C
Collezione ASL Asti

Items : 16

Clinical and microbiological features of positive blood culture episodes caused by non-fermenting gram-negative bacilli other than Pseudomonas and Acinetobacter species (2020-2023). in Infection / Infection. 2025 Feb;53(1):183-196. doi: 10.1007/s15010-024-02342-6. Epub 2024 Jul 11.

2025
ASL Asti
AOU Città della Salute di Torino

Bianco G; Costa C; De Rosa FG; Bastos P; Corcione S; Comini S; Boattini M; Casale R;

Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018-2022). in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology / Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):155-166. doi: 10.1007/s10096-023-04712-8. Epub 2023

2024
ASL Asti
AOU Città della Salute di Torino

Cavallo R; Costa C; De Rosa FG; Comini S; Corcione S; Almeida A; Bastos P; Bianco G; Boattini M;

Prevalence and Impact on Mortality of Colonization and Super-Infection by Carbapenem-Resistant Gram-Negative Organisms in COVID-19 Hospitalized Patients. in Viruses / Viruses. 2023 Sep 15;15(9):1934. doi: 10.3390/v15091934.

2023
ASL Asti
AOU Città della Salute di Torino

Rosa FG; Cavallo R; Boattini M; Comini S; Corcione S; Bastos P; Bianco G; Casale R; Costa C;

Impact of NG-Test CTX-M MULTI Immunochromatographic Assay on Antimicrobial Management of Escherichia coli Bloodstream Infections. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Feb 27;12(3):473. doi: 10.3390/antibiotics12030473.

2023
ASL Asti
AOU Città della Salute di Torino

De Rosa FG; Cavallo R; Corcione S; Comini S; Ghibaudo D; Bianco G; Boattini M; Costa C;

Bloodstream Infections by Pantoea Species: Clinical and Microbiological Findings from a Retrospective Study, Italy, 2018-2023. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Dec 13;12(12):1723. doi: 10.3390/antibiotics12121723.

2023
ASL Asti

Casale R; Boattini M; Bianco G; Comini S; Corcione S; Garazzino S; Silvestro E; De Rosa FG; Cavallo R; Costa C;

Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy. in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology / Eur J Clin Microbiol Infect Dis. 2023 Apr;42(4):431-439. doi: 10.1007/s10096-023-04577-x. Epub 2023

2023
ASL Asti
AOU Città della Salute di Torino

Costa C; De Rosa FG; Almeida A; Cavallo R; Comini S; Iannaccone M; Bianco G; Charrier L; Boattini M;

Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study in European Journal of Neurology

2023
ASL Asti

Vernieri F; Brunelli N; Marcosano M; Aurilia C; Egeo G; Lovati C; Favoni V; Perrotta A; Maestrini I; Rao R; d'Onofrio L; Finocchi C; Aguggia M; Bono F; Ranieri A; Albanese M; Di Piero V; Cevoli S; Altamura C; Barbanti P; Costa CM; Fofi L; Di Cola FS; d’Onofrio F; Bertuzzo D; Bombardieri F; Messina R; Colombo B; Filippi M; et alii...

Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trial. in BMC infectious diseases / BMC Infect Dis. 2022 Nov 22;22(1):879. doi: 10.1186/s12879-022-07716-5.

2022
ASL Asti
AO Cuneo
ASL Cuneo 1
ASL Città di Torino
ASL Torino 4
AOU San Luigi di Orbassano
ASL Torino 3
ASL VCO
ASL Vercelli

Libanore V; Blangetti I; Benedetti V; Scozzari G; Mitola B; Vitale F; Liccardi MM; Chinaglia A; Calcagno A; Bergamo D; Aldieri C; Converso M; Russo ML; Baldassano S; Canta F; Marletto FP; De Micheli AG; Mattei A; Maddalena L; Delios G; Milan M; Baffa A; Russo A; Tornello A; Nucci A; Raso S; Costa C; Pittaluga F; Avolio M; et alii...

Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience in Journal of Neurology

2022
ASL Asti

Altamura C; Brunelli N; Marcosano M; Aurilia C; Egeo G; Lovati C; Favoni V; Perrotta A; Maestrini I; Schiano Di Cola F; d’Onofrio F; Finocchi C; Bertuzzo D; Bono F; Ranieri A; Albanese M; Messina R; Doretti A; Di Piero V; Cevoli S; Barbanti P; Vernieri F; Costa CM; Fofi L; Rao R; d’Onofrio L; Spitalieri D; Aguggia M; Bombardieri F; et alii...

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-month observational, longitudinal, cohort, multicenter, Italian real-life study in European Journal of Neurology

2022
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Lovati C; Bertuzzo D; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Schiano Di Cola F; Ranieri A; Colombo B; Bono F; Albanese M; Cevoli S; Barbanti P; Pierangeli G; Capogrosso C; Aguggia M; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; et alii...

Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Cevoli S; Egeo G; Fofi L; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Di Fiore P; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in real-life in Journal of the Neurological Sciences

2021
ASL Asti

Aurilia C; Egeo G; Fofi L; Cevoli S; Messina R; Salerno A; Torelli P; Albanese M; Carnevale A; Bono F; D'Amico D; Filippi M; Altamura C; Vernieri F; Colombo B; Frediani F; Mercuri B; D'Onofrio F; Grazzi L; Aguggia M; Favoni V; Finocchi C; Fiore PD; Costa CM; Brunelli N; Fallacara A; Bertuzzo D; Zucco M; Di Clemente L; et alii...

Long-term (>48 weeks) safety and tolerability of erenumab in reallife in Journal of Headache and Pain

2021
ASL Asti

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) in Journal of Headache and Pain

2021
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Pierangeli G; Lovati C; Aguggia M; d’Onofrio F; Doretti A; Di Fiore P; Finocchi C; Rao R; Bono F; Ranieri A; Albanese M; Cevoli S; Barbanti P; Capogrosso C; Bertuzzo D; Spitaleri D; Messina S; Trogu F; Frediani F; Baldi O; Di Cola FS; et alii...

GalcanezumAb for prevention of high frequency episodic and chronic migraine in the Real Life in ITaly: A multicenter prospective cohort study (the GARLIT study) in Cephalalgia

2021
ASL Asti

Vernieri F; Altamura C; Brunelli N; Costa CM; Aurilia C; Egeo G; Fofi L; Favoni V; Pierangeli G; Lovati C; Aguggia M; Bertuzzo D; D'Onofrio F; Doretti A; Di Fiore P; Frediani F; Finocchi C; Rao R; Schiano Di Cola F; Bono F; Ranieri A; Albanese M; Cevoli S; Barbanti P;

Effectiveness, safety, and tolerability of galcanezumab in a real-life setting in patients with migraine in Italy (the GARLIT study). in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology / Neurol Sci. 2020 Dec;41(Suppl 2):487-488. doi: 10.1007/s10072-020-04669-y.

2020
ASL Asti

Vernieri F; Altamura C; Aurilia C; Brunelli N; Egeo G; Fofi L; Costa CM; Fallacara A; Favoni V; Pierangeli G; Aguggia M; Bertuzzo D; Albanese M; Di Fiore P; Frediani F; Cevoli S; Barbanti P;